Nonhuman Primate Model of Zika

Researchers infect rhesus macaques with the virus to better study its effects in humans.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Rhesus macaquesWIKIMEDIA, ARINDAM ADITYAScientists have developed a nonhuman primate model of Zika virus infection to better understand its course in humans, especially in pregnant women. David O’Connor of the University of Wisconsin-Madison and colleagues injected eight rhesus macaques—two of them pregnant—with the Asian strain of the virus currently circulating in South and Central America. The non-pregnant and pregnant monkeys were still infected 21 days and up to 57 days later, respectively, and all animals were immune to reinfection 10 weeks post-injection, the researchers reported today (June 28) in Nature Communications. Prior to publication, the team was posting its data online in real time.

“This study in a nonhuman primate provides an important contribution to our understanding of the course of Zika virus infection in primates,” Amelia Pinto of Saint Louis University, Missouri, who was not involved in the work, said in a statement sent to reporters. However, “this study is ongoing, so from the results reported in this paper we cannot yet say that macaques are going to be a good model for understanding the links between Zika infection during pregnancy and the increased risk for microcephaly,” Pinto added.

In previous, unpublished work, O’Connor and colleagues infected two pregnant macaques with Zika during the animals’ third trimesters, sacrificed the fetuses at full term, and performed necropsies on them. The team did not observe evidence of microcephaly in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies